Halifax, Canada

Donald F Weaver

USPTO Granted Patents = 23 



Average Co-Inventor Count = 4.0

ph-index = 12

Forward Citations = 419(Granted Patents)


Location History:

  • Kingston, CA (1997 - 2008)
  • Halifax, CA (2006 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Donald F. Weaver**

Introduction

Donald F. Weaver is a notable inventor based in Halifax, Canada, recognized for his impactful contributions in the field of neuroscience and biochemistry. With an impressive portfolio of 23 patents, Weaver's work focuses on methodologies that advance understanding and treatment of neurological conditions, particularly regarding amyloid protein aggregation and cognitive function assessment.

Latest Patents

Among his recent patents, Weaver has developed innovative methods for identifying inhibitors of amyloid protein aggregation. This patent describes techniques for recognizing compounds that can inhibit or potentially inhibit amyloid aggregation, along with the creation of three-dimensional, non-crystallographic models, known as 'pseudo-crystal structures', which are pivotal in these methods. Another significant patent is related to cognitive function assessment in patients. This invention outlines a comprehensive approach to analyze a patient’s conscious awareness and potential for recovery by employing a sensory stimulus sequence and performing EEG analysis to capture neural activity.

Career Highlights

Donald F. Weaver has had an impactful career, contributing substantially to the field of medical research. He has worked at notable institutions such as Queen's University at Kingston and Treventis Corporation, where he focused on the intersection of research and practical applications in neuroscience.

Collaborations

Weaver has collaborated with esteemed colleagues including Walter A. Szarek and Richard J. Riopelle. Their joint efforts have furthered research and innovations in understanding complex neurological conditions and developing therapeutic strategies.

Conclusion

In conclusion, Donald F. Weaver’s innovative work and extensive patent portfolio reflect his dedication to advancing medical science and improving patient outcomes. His contributions, particularly in the areas of amyloid protein research and cognitive assessments, are a testament to his significant role within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…